Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan)“
Suchtreffer
Begriffe & Kennungen
Darunavir Viatris (previously Darunavir Mylan) · 4.3 · Co-administration with the combination product lopinavir/ritonavir (see section 4.5).
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan)
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.1 Therapeutic indications · 1
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.3 Contraindications · 1
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.3 · 4 Medicinal product Medicinal products within Rationale class class Antianginal Ranolazine Increased plasma co
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.3 · 5 Medicinal product Medicinal products within Rationale class class HMG Co-A Reductase Lovastatin, simvastatin
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.3 · Lopinavir/Ritonavir Viatris tablets contain lopinavir and ritonavir, both of which are inhibitors of the P450
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.3 · Medicinal product Medicinal products within Rationale class class Concomitant medicinal product levels increas
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.3 · Severe hepatic insufficiency.
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.5 · (combinations of mechanisms including CYP3A inhibition)
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.5 · (inhibition of CYP3A enzymes) HIV CCR5 – antagonist Maraviroc Maraviroc: The dose of maraviroc should be AUC:
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.5 · 10 Co-administered drug by Effects on drug levels Clinical recommendation therapeutic area Geometric Mean Chan
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.5 · 11 Co-administered drug by Effects on drug levels Clinical recommendation therapeutic area Geometric Mean Chan
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.5 · 12 Co-administered drug by Effects on drug levels Clinical recommendation therapeutic area Geometric Mean Chan
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.5 · 13 Co-administered drug by Effects on drug levels Clinical recommendation therapeutic area Geometric Mean Chan
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.5 · 14 Co-administered drug by Effects on drug levels Clinical recommendation therapeutic area Geometric Mean Chan
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.5 · 15 Co-administered drug by Effects on drug levels Clinical recommendation therapeutic area Geometric Mean Chan
Eintrag öffnen